Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$692 Sell
8
-10
-56% -$854 ﹤0.01% 3227
2026
Q1
$1.61K Buy
18
+2
+13% +$192 ﹤0.01% 2916
2025
Q4
$1.49K Sell
16
-19
-54% -$2.07K ﹤0.01% 2843
2025
Q3
$4.36K Buy
35
+4
+13% +$509 ﹤0.01% 2392
2025
Q2
$4.08K Buy
31
+13
+72% +$1.47K ﹤0.01% 2191
2025
Q1
$1.89K Sell
18
-158
-90% -$16.5K ﹤0.01% 2182
2024
Q4
$19.1K Buy
176
+161
+1,073% +$18K ﹤0.01% 1666
2024
Q3
$1.6K Sell
15
-4
-21% -$405 ﹤0.01% 1917
2024
Q2
$1.88K Buy
+19
New +$1.91K ﹤0.01% 1757
2022
Q2
Sell
-40
Closed -$2K 1585
2022
Q1
$2K Buy
+40
New +$2.24K ﹤0.01% 1418
2018
Q1
Sell
-16
Closed -$1K 1688
2017
Q4
$1K Buy
16
+11
+220% +$786 ﹤0.01% 1632
2017
Q3
$0 Buy
+5
New +$363 ﹤0.01% 1540

Other funds holding ITRI

AssetMark Inc's ITRI Position: Q2 2026 in Review

AssetMark Inc reduced its Itron (ITRI) stake by 56% in Q2 2026, selling an estimated $854 and leaving 8 shares worth $692. The position accounts for ﹤0.01% of the portfolio, ranked #3227.

AssetMark Inc first reported a position in ITRI in Q3 2017 and has held it in 12 quarters since. The position peaked at $19.1K in Q4 2024. 158 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • AssetMark Inc held 8 shares of Itron worth $692 as of Q2 2026.
  • AssetMark Inc sold 10 Itron shares in Q2 2026, an estimated $854.
  • Itron made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3227 holding.
  • AssetMark Inc first reported a position in Itron in Q3 2017 and has held it in 12 quarters since.
  • AssetMark Inc's Itron position peaked at $19.1K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.